Henrik Frederiksen

Henrik Frederiksen is a Professor in Haematology at the Department of Clinical Research, University of Southern Denmark, and serves as a Consultant at Odense University Hospital (OUH). He holds multiple leadership positions including Head of Research at OUH's Department of Haematology, Chairman of the Scientific Council at the Danish Comprehensive Cancer Center, and board member of the Danish Multidisciplinary Cancer Groups. He coordinates European Hematology Association guidelines and leads epidemiology research at AgeCare elite research centre.

Education:

• MD, Odense University (1997)
• PhD in Genetic Epidemiology, University of Southern Denmark (2003)
• Diploma in Medical Research (Haematology), Odense University (1997)
• Specialist in Internal Medicine: Haematology (2010)

Research Focus: His work spans benign haematology, cancer-associated aging/frailty, supportive care, and epidemiological studies. He investigates hematological disorders through nationwide cohort analyses, molecular diagnostics, and clinical outcome assessments, with emphasis on thrombocytopenia, leukemia, and treatment toxicity.

Publication Trends: Recent articles (2025) demonstrate methodological diversity including multi-omics approaches, registry-based cohort studies, and clinical case analyses. Dominant themes include hematological malignancy management, drug response evaluation, and complication prevention in immunotherapies.

Academic Leadership:

• Supervised 8 completed PhDs and 6 ongoing PhD students
• Leads hematology curriculum development at SDU medical school
• Organizes international PhD courses (e.g., Immunotherapy in Haematology)

Collaborative Networks: Heads epidemiology at AgeCare research center, chairs national research strategy implementation, and participates in Nordic/European hematology working groups including EHA guideline committees.